The era of 100% source data verification is officially becoming a thing of the past. Clinical trial monitoring is undergoing a massive shift, and this latest R3 guidance isn't starting a new trend—it's just catching up to one. Expect to see fewer on-site visits, more remote read-only access, and a heavier reliance on centralized monitoring moving forward. The industry is evolving, and those relying on outdated, manual processes are quickly getting left behind. #ClinicalTrials #PharmaTech #ClinicalResearch #DataMonitoring #ClinicalOperations - @dansfera